Literature DB >> 9438687

Chemotherapy for non-small cell lung cancer: the experience of the Lung Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer.

P E Postmus1.   

Abstract

The Lung Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer was founded in 1981. During the past 15 years, the group has participated in the development of treatment of non-small cell lung cancer with chemotherapy. The group performed standard phase II studies of new drugs and phase III studies with new and active drugs. Furthermore, the group performed studies combining chemotherapy with treatment for localized disease.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9438687     DOI： 10.1378/chest.113.1_supplement.28s

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


  7 in total

1.  PD-1 gene promoter polymorphisms correlate with a poor prognosis in non-small cell lung cancer.

Authors:  Hidefumi Sasaki; Tsutomu Tatemaysu; Katsuhiro Okuda; Satoru Moriyama; Motoki Yano; Yoshitaka Fujii
Journal:  Mol Clin Oncol       Date:  2014-07-24

2.  Increased Sox2 copy number in lung squamous cell carcinomas.

Authors:  Hidefumi Sasaki; Keisuke Yokota; Yu Hikosaka; Satoru Moriyama; Motoki Yano; Yoshitaka Fujii
Journal:  Exp Ther Med       Date:  2011-10-21       Impact factor: 2.447

3.  Angiopoietin-like protein ANGPTL2 gene expression is correlated with lymph node metastasis in lung cancer.

Authors:  Hidefumi Sasaki; Ayumi Suzuki; Masayuki Shitara; Yu Hikosaka; Katsuhiro Okuda; Satoru Moriyama; Motoki Yano; Yoshitaka Fujii
Journal:  Oncol Lett       Date:  2012-09-20       Impact factor: 2.967

4.  Investigation of neurotrophic tyrosine kinase receptor 1 fusions and neurotrophic tyrosine kinase receptor family expression in non-small-cell lung cancer and sensitivity to AZD7451 in vitro.

Authors:  Tsutomu Tatematsu; Hidefumi Sasaki; Shigeki Shimizu; Katsuhiro Okuda; Masayuki Shitara; Yu Hikosaka; Satoru Moriyama; Motoki Yano; Jeffrey Brown; Yoshitaka Fujii
Journal:  Mol Clin Oncol       Date:  2014-06-19

5.  PD-L1 gene expression in Japanese lung cancer patients.

Authors:  Hidefumi Sasaki; Ayumi Suzuki; Masayuki Shitara; Yu Hikosaka; Katsuhiro Okuda; Satoru Moriyama; Motoki Yano; Yoshitaka Fujii
Journal:  Biomed Rep       Date:  2012-09-19

6.  Increased BRAF copy number in lung adenocarcinoma.

Authors:  Hidefumi Sasaki; Masahiko Maekawa; Tsutomu Tatematsu; Katsuhiro Okuda; Satoru Moriyama; Motoki Yano; Yoshitaka Fujii
Journal:  Oncol Lett       Date:  2014-11-20       Impact factor: 2.967

7.  APOBEC3B gene overexpression in non-small-cell lung cancer.

Authors:  Hidefumi Sasaki; Ayumi Suzuki; Tsutomu Tatematsu; Masayuki Shitara; Yu Hikosaka; Katsuhiro Okuda; Satoru Moriyama; Motoki Yano; Yoshitaka Fujii
Journal:  Biomed Rep       Date:  2014-03-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.